Differential diagnosis of membranous nephropathy with autoantibodies to phospholipase A2 receptor 1 (original ) (raw )Idiopathic membranous nephropathy and anti-phospholipase A2 receptor antibodies
Arif Asif , Ali Nayer
Journal of nephropathology, 2013
View PDFchevron_right
Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases
Francesca Pregnolato
Journal of Nephrology, 2017
View PDFchevron_right
Detection of Phospholipase A2 Receptor Related Membranous Nephropathy in Membranous Nephropathy Patient
Alaa Elmaghraby
SVU-International Journal of Medical Sciences, 2020
View PDFchevron_right
Autoantibodies against phospholipase A2 receptor in Brazilian patients with glomerular diseases
Gianna Mastroianni Kirsztajn
International Urology and Nephrology, 2020
View PDFchevron_right
Anti-phospholipase A2 receptor antibodies in the diagnosis of idiopathic membranous nephropathy
H. Viana
View PDFchevron_right
Faculty of 1000 evaluation for M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy
David Goldsmith
F1000 - Post-publication peer review of the biomedical literature, 2009
View PDFchevron_right
Diagnostic accuracy of anti-phospholipase A2 receptor (PLA2R) antibodies in idiopathic membranous nephropathy: an Italian experience
Marilina Tampoia
Journal of Nephrology, 2020
View PDFchevron_right
Antiphospholipase A2 Receptor Autoantibodies: A Step Forward in the Management of Primary Membranous Nephropathy
Andreea Andronesi
BioMed Research International, 2015
View PDFchevron_right
Anti-phospholipase A2 receptor antibody in membranous nephropathy; an Indian experience
sonia mehrotra
Journal of Renal Injury Prevention
View PDFchevron_right
Antiphospholipase A 2 Receptor Autoantibodies: A Comparison of Three Different Immunoassays for the Diagnosis of Idiopathic Membranous Nephropathy
Marvin Fritzler
Journal of Immunology Research, 2014
View PDFchevron_right
Autoantibodies Specific for the Phospholipase A2 Receptor in Recurrent and De Novo Membranous Nephropathy
C. Mousson
American Journal of Transplantation, 2011
View PDFchevron_right
Circulating anti-phospholipase A2 receptor antibodies as a diagnostic and prognostic marker in Greek patients with idiopathic membranous nephropathy – a retrospective cohort study
Dimitra Kalavrizioti
Romanian Journal of Internal Medicine
View PDFchevron_right
Role of phospholipase A2 receptor 1 antibody level at diagnosis for long-term renal outcome in membranous nephropathy
Mohd Fauzi
PLOS ONE, 2019
View PDFchevron_right
Phospholipase A2 receptor (PLA2R) related membranous nephropathy - not specific for idiopathic cases any more
Bahar Bastani
Journal of Nephropathology
View PDFchevron_right
Evaluation of anti-PLA2R1 as measured by a novel ELISA in patients with idiopathic membranous nephropathy: a cohort study
jan willem cohen tervaert
American journal of clinical pathology, 2014
View PDFchevron_right
Antiphospholipase A2 Receptor Antibody Titer and Subclass in Idiopathic Membranous Nephropathy
P. Ronco
Journal of the American Society of Nephrology, 2012
View PDFchevron_right
Coexistence of ANCA-associated glomerulonephritis and anti-phospholipase A(2) receptor antibody-positive membranous nephropathy
Rivka Ayalon
Clinical kidney journal, 2012
View PDFchevron_right
A Comprehensive Phenotypic and Functional Immune Analysis Unravels Circulating Anti–Phospholipase A2 Receptor Antibody Secreting Cells in Membranous Nephropathy Patients
Umberto Maggiore
Kidney International Reports, 2020
View PDFchevron_right
Anti-Phospholipase A2 Receptor Antibodies in Recurrent Membranous Nephropathy
Sanjeev Sethi
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2015
View PDFchevron_right
Circulating antibodies to α-enolase and phospholipase A2 receptor and composition of glomerular deposits in Japanese patients with primary or secondary membranous nephropathy
Hanna Debiec
Clinical and Experimental Nephrology, 2016
View PDFchevron_right
Anti-PLA2R-associated membranous nephropathy: a review with emphasis on diagnostic testing methods
Mark Haas
Clinical Nephrology, 2015
View PDFchevron_right
The serum level of anti-phospholipase A2 receptor antibody does not predict severity of proteinuria in primary membranous glomerulonephritis
nazanin samandari
Journal of Renal Injury Prevention, 2020
View PDFchevron_right
Antiphospholipase A2 receptor autoantibody guided diagnosis and treatment of membranous nephropathy: a new personalized medical approach
Richard Glassock
Clinical journal of the American Society of Nephrology : CJASN, 2014
View PDFchevron_right
Anti–Phospholipase A2 Receptor Antibodies and Malignancy in Membranous Nephropathy
P. van Paassen , jan willem cohen tervaert
American Journal of Kidney Diseases, 2013
View PDFchevron_right
Identification of the immunodominant epitope region in phospholipase A2 receptor-mediating autoantibody binding in idiopathic membranous nephropathy
Richard Glassock
Journal of the American Society of Nephrology : JASN, 2015
View PDFchevron_right
Development of a Standardized Chemiluminescence Immunoassay for the Detection of Autoantibodies Against Human M-Type Phospholipase A2 Receptor in Primary Membranous Nephropathy
Sandra Saschenbrecker
Kidney International Reports, 2019
View PDFchevron_right
M-type phospholipase A2 receptor (PLA2R) glomerular staining in pediatric idiopathic membranous nephropathy
Takeshi Yanagihara
Pediatric nephrology (Berlin, Germany), 2017
View PDFchevron_right
Antibodies to m-type phospholipase A2 receptor in children with idiopathic membranous nephropathy.
Vivekanand Jha
View PDFchevron_right
Combined Plasmatic and Tissue Approach to Membranous Nephropathy—Proposal of a Diagnostic Algorithm Including Immunogold Labelling: Changing the Paradigm of a Serum-based Approach
Antonella Tosoni
Applied Immunohistochemistry & Molecular Morphology, 2019
View PDFchevron_right
Membranous nephropathy: diagnosis, treatment, and monitoring in the post-PLA2R era
Rivka Ayalon
Pediatric Nephrology, 2019
View PDFchevron_right